Correlation Between Stoke Therapeutics and Sutro Biopharma
Can any of the company-specific risk be diversified away by investing in both Stoke Therapeutics and Sutro Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Stoke Therapeutics and Sutro Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Stoke Therapeutics and Sutro Biopharma, you can compare the effects of market volatilities on Stoke Therapeutics and Sutro Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Stoke Therapeutics with a short position of Sutro Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Stoke Therapeutics and Sutro Biopharma.
Diversification Opportunities for Stoke Therapeutics and Sutro Biopharma
0.77 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Stoke and Sutro is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Stoke Therapeutics and Sutro Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sutro Biopharma and Stoke Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Stoke Therapeutics are associated (or correlated) with Sutro Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sutro Biopharma has no effect on the direction of Stoke Therapeutics i.e., Stoke Therapeutics and Sutro Biopharma go up and down completely randomly.
Pair Corralation between Stoke Therapeutics and Sutro Biopharma
Given the investment horizon of 90 days Stoke Therapeutics is expected to generate 1.15 times more return on investment than Sutro Biopharma. However, Stoke Therapeutics is 1.15 times more volatile than Sutro Biopharma. It trades about 0.03 of its potential returns per unit of risk. Sutro Biopharma is currently generating about -0.01 per unit of risk. If you would invest 1,269 in Stoke Therapeutics on August 31, 2024 and sell it today you would lose (58.00) from holding Stoke Therapeutics or give up 4.57% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Stoke Therapeutics vs. Sutro Biopharma
Performance |
| Timeline |
| Stoke Therapeutics |
| Sutro Biopharma |
Stoke Therapeutics and Sutro Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Stoke Therapeutics and Sutro Biopharma
The main advantage of trading using opposite Stoke Therapeutics and Sutro Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Stoke Therapeutics position performs unexpectedly, Sutro Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sutro Biopharma will offset losses from the drop in Sutro Biopharma's long position.| Stoke Therapeutics vs. Adaptimmune Therapeutics Plc | Stoke Therapeutics vs. Black Diamond Therapeutics | Stoke Therapeutics vs. Relay Therapeutics | Stoke Therapeutics vs. Pliant Therapeutics |
| Sutro Biopharma vs. Cue Biopharma | Sutro Biopharma vs. Eliem Therapeutics | Sutro Biopharma vs. Inhibrx | Sutro Biopharma vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |